ImmunoGen Announces Conference Call to Discuss Its First Quarter 2021 Operating Results

Rhea-AI Summary

ImmunoGen Inc. (Nasdaq: IMGN) will host a conference call on May 10, 2021, at 8:00 a.m. ET to discuss its first-quarter operating results and provide a business update. Investors can join the call by dialing (877) 621-5803, using conference ID 9982696, or accessing it through the company’s website. ImmunoGen focuses on developing advanced antibody-drug conjugates (ADCs) aimed at improving cancer treatment outcomes, highlighting its commitment to TARGET A BETTER NOW™.

Positive

• Focused on development of next-generation ADCs to improve cancer treatment.
• Commitment to enhancing anti-tumor activity and tolerability for patients.

Negative

• None.

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Monday, May 10, 2021 to discuss its first quarter operating results. Management will also provide a brief update on the business.

Conference Call Information

To access the live call by phone, dial (877) 621-5803; the conference ID is 9982696. The call may also be accessed through the Investors and Media section of the Company’s website, www.immunogen.com. Following the call, a replay will be available at the same location.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210426005775/en/

FAQ

When is the ImmunoGen conference call scheduled?

The ImmunoGen conference call is scheduled for May 10, 2021, at 8:00 a.m. ET.

What is the purpose of the ImmunoGen conference call?

The conference call will discuss ImmunoGen's first-quarter operating results and provide a business update.

How can I access the ImmunoGen conference call?

You can access the live call by dialing (877) 621-5803 or through the Investors and Media section of ImmunoGen's website.

What is ImmunoGen's commitment to cancer treatment?

ImmunoGen is focused on developing next-generation antibody-drug conjugates to improve outcomes for cancer patients.